Short oral regimens for pulmonary rifampicinresistant tuberculosis TBPRACTECAL an openlabel randomised controlled phase 2B3 multiarm multicentre noninferiority trial
dc.article.end-page | 128 | en |
dc.article.start-page | 117 | en |
dc.citation.doi | 10.1016/S2213-2600(23)00389-2 | en |
dc.contributor.author | Bern-Thomas Nyang'wa | en |
dc.contributor.author | C Berry | en |
dc.contributor.author | Emil Kazounis | en |
dc.contributor.author | I Motta | en |
dc.contributor.author | Mohammed Rassool | en |
dc.date.accessioned | 2025-03-28T09:58:45Z | |
dc.faculty | FACULTY OF HEALTH SCIENCES | en |
dc.identifier.citation | WOS | en |
dc.identifier.issn | 2213-2600 | en |
dc.identifier.uri | https://hdl.handle.net/10539/44485 | |
dc.journal.title | Short oral regimens for pulmonary rifampicinresistant tuberculosis TBPRACTECAL an openlabel randomised controlled phase 2B3 multiarm multicentre noninferiority trial | en |
dc.journal.volume | 12 | en |
dc.publisher | ELSEVIER SCI LTD | en |
dc.title | Short oral regimens for pulmonary rifampicinresistant tuberculosis TBPRACTECAL an openlabel randomised controlled phase 2B3 multiarm multicentre noninferiority trial | en |
dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Journal Article.pdf
- Size:
- 589.83 KB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client